Stereospecific activity of two glutamate analogs

Chirality

Volumn 16, Issue 9, 2004, Pages 586-591

  Araujo Alvarez, Juan Manuel ^a   Querejeta, Enrique ^a   Oviedo, Aldo ^a   Trujillo Ferrara, José G ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

(+) (S) and ( ) (R) Trujillon; Convulsant response; Globus pallidus; Glutamatergic activity; Neuronal electrical activity

Indexed keywords

4 (2,2 DIPHENYL 1,3,2 OXAZABOROLIDIN 5 OXO)PROPIONIC ACID; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG STRUCTURE; FEMALE; GLOBUS PALLIDUS; HORMONE RECEPTOR INTERACTION; IN VIVO STUDY; LETHAL DOSE; MALE; MORTALITY; MOTOR ACTIVITY; MOUSE; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOSPECIFICITY;

ANIMALS; BORON COMPOUNDS; CONVULSANTS; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS; FEMALE; GLOBUS PALLIDUS; GLUTAMATES; GLUTAMIC ACID; INDICATORS AND REAGENTS; INJECTIONS, INTRAVENOUS; LETHAL DOSE 50; MICE; NEURONS; STEREOISOMERISM; TELENCEPHALON;

EID: 7044224758     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/chir.20072     Document Type: Article

References (25)

1. Gaviraghi G. Excitatory amino acid receptors. Pharm Acta Helv 2000;74:219-220.
2. Kandel ER, Schwartz JH, Jessell TM. Principles of neural science, 3rd ed. New York: Elsevier; 1994. Chap 9-14.
3. Trist DG. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications. Pharm Acta Helv 2000;74:221-229.
4. Siegel GJ, Agranoff BW, Albers RW, Molinoff PB. Basic neurochemistry, 5th ed. New York: Raven Press; 1994. Chap 10, 11.
5. Feldman RS, Meyer JS, Quenzer LF. The amino acid neurotransmitters and histamine. In: Principles of neuropsychopharmacology. Sunderland, MA: Sinauer Associates; 1997. p 391-350.
6. Trujillo-Ferrara J, Vázquez A, Espinosa J, Santillan R, Farfán N, Höpfl H. Reversible and irreversible inhibitory activity of succinic and maleic acid derivates on acetylcholinesterase. Eur J Pharmacol Sci 2003; 18:313-322.
7. Trejtnar F, Král R, Pávek P, Wsól V. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs. Chirality 2003;15:724-729.
8. Farfán N, Silva D, Santilĺan R. NMR studies of 1,1, diphenylboroxazolidone derivatives of α-amino acids. Heteroat Chem 1993;6: 533-536.
9. Nefkes G, Zwanenburg B. Boroxazolidones as simultaneous protection of the amino and carboxyl group in α-amino acids. Tetrahedrom 1983;39:2995-2998.
10. Reting ST, Trotter J. Crystal and molecular estructure of L-prolinatodiphenylboron. Can J Chem 1997;55:958-965.
11. Trujillo FJ, Hôpfl H, Castillo D, Santillán R, Farfán NJ. X-ray crystallographic study of boroxazolidones obtained from L-ornithine, L-methionine, kainic acid and 2,6-pyridinedicarboxylic acid. Organomet Chem 1998;571:31-39.
12. Götz T, Kraushar U, Geiger J, Lübke J, Berger T, Jonas P. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J Neurosci 1997;17:204-215.
13. Poisik OV, Mannaioni G, Traynelis S, Smith Y, Conn J. Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus. J Neurosci 2003;23:122-130.
14. Soltis RP, Anderson LA, Walters JR, Kelland MD. A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus. Brain Res 1994;666:21-30.
15. De Long MR, Crutcher MD, Georgopoulos AP. Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 1985;53:530-543.
16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 4th ed. New York: Academic Press; 1998.
17. Soto E, Vega RA. Turbo Pascal program for on line spike data analysis using a standard serial port. J Neurosci Meth 1987;86:61-68.
18. Lehmann PA. Dosis letal o efectiva media: Un cálculo manual fácil y rápido. Arch Farm Toxicol 1980;2:161-177.
19. Chevalier G, Vacher J, Deniau JM, Desban M. Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res 1985; 334:215-226.
20. Deniau JM, Chevalier G. Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res 1985;334:227-233.
21. Ronald V, Dorn III MD. Boron neutron capture therapy (BCNT): a radiation oncology perspective. Int J Radiat Oncol Biol Phys 1994;5: 1189-1201.
22. Groziak MP. Boron therapeutics on the horizons. Am J Ther 2001;8: 321-328.
23. Groziak MP. Boron heterocycles as platform for building new bioactive agents. In: Gribble GW, Gilchrist TL, editors. Progress in Heterocyclic Chemistry. Oxford: Elsevier Science; 2000. p 1-21.
24. Eliel EL. Stereochemistry of carbon compounds. New York: McGraw-Hill; 1962. p 412-427.
25. Marcotte E, Pearson D, Srivastava L. Animal models of schizophrenia: a critical review. J Psych Neurosci 2001;5:395-410.